"Medicare Expands Coverage to Include Weight-Loss Drug Wegovy for Heart Disease Patients"

Medicare will now cover Wegovy for patients at risk of heart disease, following the FDA's expanded approval for the weight loss medication. While Medicare won't cover Wegovy for weight management alone, it will provide coverage for those at risk of heart disease. This decision could grant millions of patients access to the expensive drug, but experts warn of potential financial strain on Medicare due to the drug's high cost. Medicaid will also be required to cover Wegovy for reducing heart disease risk, and private insurance companies offering supplemental Part D coverage may need to consider their response to this change.